SRM Institute of Science and Technology (SRMIST) has started the SRM Joint Engineering Entrance Examination (SRMJEEE) 2025 slot booking for phase 1. Candidates can select their preferred exam ...

Health and Human Services Secretary Robert F. Kennedy Jr. and the Food and Drug Administration announced a plan to phase out petroleum-based dyes in food by the end of 2026. Photo: Andrew Harnik ...

LITTLE ROCK (KATV) — Pulaski County is set to announce the completion of Phase 1 of the Southwest Trail this morning, government officials said in a release. The Southwest Trail is a planned 65 ...

Consider this phase two of the US military’s AI push, where phase one began back in 2017 with older types of AI, like computer vision to analyze drone imagery. Though this newest phase began ...

SRMJEE 2025 Phase 1 application for admissions into B.Tech courses in various SRM colleges ends today, April 16, 2025. Interested and eligible candidates can apply through the official website of ...

SSC Selection Post Phase 13 Notification 2025: The Staff Selection Commission (SSC) will release the SSC Selection Post Phase 13 Notification 2025 soon on its official website to recruit eligible ...

The agencies aim to remove the dyes by the end of next year. The Department of Health and Human Services and the Food and Drug Administration announced on Tuesday a series of measures to phase out ...

WASHINGTON – For Harvard University, the cavalry has arrived. When the nation’s oldest and richest college first rebuked the Trump administration last Monday amid efforts to force changes to ...

PRINCETON, N.J., April 14, 2025--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients ...

This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here ...

Get Instant Summarized Text (Gist) The FDA is transitioning from animal testing to more human-relevant methods in drug development, particularly for monoclonal antibody therapies. This approach ...